Stockscreener 앱 받기
0.00
100.00%
-29.08
Mersana Therapeutics Inc 주식(MRSN)의 최신 뉴스
How The Day One Deal Is Reshaping The Story For Mersana Therapeutics (MRSN) - Yahoo Finance
Day One concludes Mersana Therapeutics acquisition - Yahoo Finance
Day One Biopharmaceuticals completes acquisition of Mersana Therapeutics By Investing.com - Investing.com Nigeria
Day One Biopharmaceuticals completes acquisition of Mersana Therapeutics - Investing.com
Mersana Therapeutics Completes Merger and Delists from Nasdaq - TipRanks
Day One Biopharmaceuticals Completes Acquisition of Mersana Therapeutics - TipRanks
Mersana Therapeutics Announced Transfer or Voluntary Withdrawal of Listing - TradingView — Track All Markets
Day One Biopharmaceuticals Completes Acquisition of Mersana Therapeutics to Enhance Oncology Pipeline - Quiver Quantitative
Day One Completes Acquisition of Mersana Therapeutics - GlobeNewswire
Mersana Therapeutics, Inc.(NasdaqGS: MRSN) dropped from S&P TMI Index - MarketScreener
Panic Selling: Is Mersana Therapeutics Inc stock positioned for long term growthWeekly Risk Report & AI Driven Stock Reports - moha.gov.vn
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Receives Consensus Rating of "Reduce" from Brokerages - MarketBeat
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alexander & Baldwin, Inc. (NYSEALEX), United Security Bancshares (NasdaqUBFO), Udemy, Inc. (NasdaqUDMY), Mersana Therapeutics, Inc. (Nasdaq - GlobeNewswire Inc.
How The Mersana Deal Is Rewriting The Story Behind Day One Biopharmaceuticals Valuation - Yahoo Finance
MRSN (Mersana Therapeutics) EV-to-OCF : -1.23 (As of Dec. 22, 2025) - GuruFocus
Fund Flows: How Mersana Therapeutics Inc. (0M4) stock compares with market leadersJuly 2025 Fed Impact & Weekly High Conviction Trade Ideas - Улправда
Is Mersana Therapeutics Inc. stock trading at a premium valuationJuly 2025 Decliners & Intraday High Probability Setup Alerts - Улправда
What insider trading reveals about Mersana Therapeutics Inc. stockWeekly Stock Report & Free Community Supported Trade Ideas - Улправда
Mersana Therapeutics Earnings Notes - Trefis
Will Mersana Therapeutics Inc. stock maintain momentum in 2025July 2025 EndofMonth & High Win Rate Trade Alerts - DonanımHaber
Is Mersana Therapeutics Inc. stock a buy before product launchesLayoff News & Safe Entry Point Identification - DonanımHaber
How Mersana Therapeutics Inc. stock performs in interest rate cyclesQuarterly Market Summary & Real-Time Buy Zone Alerts - Улправда
Mersana Therapeutics, Inc.(NasdaqGS: MRSN) dropped from NASDAQ Biotechnology Index - marketscreener.com
Is Mersana Therapeutics Inc. stock cheap compared to fundamentals2025 Market WrapUp & Verified High Yield Trade Plans - Улправда
How Mersana Therapeutics Inc. (0M4) stock compares with market leaders2025 Earnings Impact & Real-Time Volume Analysis - Улправда
Halper Sadeh LLC Encourages MRSN, CDTX, RYI Shareholders to Contact the Firm to Discuss Their Rights - Sahm
Shareholder Alert: The Ademi Firm continues to investigate wheth - GuruFocus
Shareholder Alert: The Ademi Firm continues to investigate whether Mersana Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders - PR Newswire
Luminus Management LLC Sells 989,314 Shares of Mersana Therapeutics, Inc. $MRSN - MarketBeat
Why Analysts See Mersana’s Story Shifting To Deal And CVR Outcomes After $1B Buyout - Yahoo Finance
Halper Sadeh LLC Encourages FFWM, MRSN, FSUN Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
683 Capital Management LLC Boosts Stock Position in Mersana Therapeutics, Inc. $MRSN - MarketBeat
Mersana Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Mersana Therapeutics, Inc.MRSN - PR Newswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
News - FinancialContent
Why The Narrative Around Day One Biopharmaceuticals Is Shifting After The Mersana Acquisition - Yahoo Finance
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-SMLR, MRSN, CDTX, and RYI - The Malaysian Reserve
Day One Biopharmaceuticals Expands with Mersana Acquisition - StocksToTrade
Is Mersana Therapeutics Inc 0M4 a good long term investmentLarge Cap Stability Picks & High Return Trading Ideas - earlytimes.in
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger—SMLR, MRSN, CDTX, and RYI - Morningstar
Mersana Therapeutics (MRSN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
MRSN Stock Soars Over 200% Pre-Market After Day One Acquisition Deal - MSN
Day One to buy Mersana Therapeutics for $25/share upfront - MSN
Is Mersana Therapeutics Inc. (0M4) stock prepared for digital transitionRate Hike & Daily Growth Stock Investment Tips - Newser
Can Mersana Therapeutics Inc. (0M4) stock stage a strong rebound this quarter - Newser
Can Mersana Therapeutics Inc. (0M4) stock sustain breakout momentumJuly 2025 PreEarnings & High Accuracy Investment Entry Signals - Newser
Why Mersana Therapeutics Inc. (0M4) stock could be next leaderJuly 2025 Opening Moves & Community Consensus Stock Picks - Newser
How Mersana Therapeutics Inc. (0M4) stock compares with top peersQuarterly Earnings Summary & Fast Gain Stock Trading Tips - Newser
Will Mersana Therapeutics Inc. (0M4) stock attract long term capital inflowsJuly 2025 Review & Consistent Income Trade Ideas - Newser
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Given Consensus Recommendation of "Reduce" by Brokerages - MarketBeat
Will Mersana Therapeutics Inc. (0M4) stock deliver compounding returnsQuarterly Trade Report & Breakout Confirmation Alerts - Newser
Options Flow: How Mersana Therapeutics Inc. (0M4) stock compares with market leadersJuly 2025 Setups & Daily Technical Forecast Reports - moha.gov.vn
How Mersana’s Acquisition Is Changing the Story and Analyst Outlook for Investors - Yahoo Finance
Halper Sadeh LLC Encourages SEMR, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights - Sahm
HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the MergerEXAS, SEE, CDTX, and MRSN - The Malaysian Reserve
0.80%
4.56%
자본화:
|
볼륨(24시간):